This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
Conditions
Chronic Obstructive Pulmonary Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site, Anhui, China
Research Site, Anning, China
Research Site, Beijing, China
Research Site, Binzhou, China
Research Site, Changzhou, China
Research Site, Fenyang, China
Research Site, Guangdong, China
Research Site, Guangzhou, China
Research Site, Hangzhou, China
Research Site, Huzhou, China
Research Site, Jiaxing, China
Research Site, Jinan, China
Research Site, Jinhua, China
Research Site, Jining, China
Research Site, Jiyuan, China
Research Site, Kunshan, China
Research Site, Linyi, China
Research Site, Mianyang, China
Research Site, Nanbu, China
Research Site, Nanchang, China
Research Site, Nanjing, China
Research Site, Ningbo, China
Research Site, Shanghai, China
Research Site, Shanxi, China
Research Site, Shenzhen, China
Research Site, Shijiazhuang, China
Research Site, Suining, China
Research Site, Taiyuan, China
Research Site, Weifang, China
Research Site, Wuhan, China
Research Site, Wuxi, China
Research Site, Xi'an, China
Research Site, Xiamen, China
Research Site, Zhangjiagang, China
Research Site, Zhengzhou, China
Research Site, Zhenjiang, China
Study leads
chen wang, PhD
Principal Investigator
China-Japan Friendship Hospital